255 related articles for article (PubMed ID: 24098125)
1. Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity.
Lucas-Hourani M; Dauzonne D; Jorda P; Cousin G; Lupan A; Helynck O; Caignard G; Janvier G; André-Leroux G; Khiar S; Escriou N; Desprès P; Jacob Y; Munier-Lehmann H; Tangy F; Vidalain PO
PLoS Pathog; 2013; 9(10):e1003678. PubMed ID: 24098125
[TBL] [Abstract][Full Text] [Related]
2. [Stimulation of the antiviral innate immune response by pyrimidine biosynthesis inhibitors: a surprise of phenotypic screening].
Vidalain PO; Lucas-Hourani M; Helynck O; Tangy F; Munier-Lehmann H
Med Sci (Paris); 2015 Jan; 31(1):98-104. PubMed ID: 25658737
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
[TBL] [Abstract][Full Text] [Related]
4. Original Chemical Series of Pyrimidine Biosynthesis Inhibitors That Boost the Antiviral Interferon Response.
Lucas-Hourani M; Dauzonne D; Munier-Lehmann H; Khiar S; Nisole S; Dairou J; Helynck O; Afonso PV; Tangy F; Vidalain PO
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28807907
[No Abstract] [Full Text] [Related]
5. Atovaquone Inhibits Arbovirus Replication through the Depletion of Intracellular Nucleotides.
Cifuentes Kottkamp A; De Jesus E; Grande R; Brown JA; Jacobs AR; Lim JK; Stapleford KA
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894466
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
[TBL] [Abstract][Full Text] [Related]
7. Chikungunya virus: an update on antiviral development and challenges.
Kaur P; Chu JJ
Drug Discov Today; 2013 Oct; 18(19-20):969-83. PubMed ID: 23684571
[TBL] [Abstract][Full Text] [Related]
8. C6orf106 is a novel inhibitor of the interferon-regulatory factor 3-dependent innate antiviral response.
Ambrose RL; Liu YC; Adams TE; Bean AGD; Stewart CR
J Biol Chem; 2018 Jul; 293(27):10561-10573. PubMed ID: 29802199
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses.
Sali TM; Pryke KM; Abraham J; Liu A; Archer I; Broeckel R; Staverosky JA; Smith JL; Al-Shammari A; Amsler L; Sheridan K; Nilsen A; Streblow DN; DeFilippis VR
PLoS Pathog; 2015 Dec; 11(12):e1005324. PubMed ID: 26646986
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response.
Olagnier D; Scholte FE; Chiang C; Albulescu IC; Nichols C; He Z; Lin R; Snijder EJ; van Hemert MJ; Hiscott J
J Virol; 2014 Apr; 88(8):4180-94. PubMed ID: 24478443
[TBL] [Abstract][Full Text] [Related]
11. Viral Polymerase-Helicase Complexes Regulate Replication Fidelity To Overcome Intracellular Nucleotide Depletion.
Stapleford KA; Rozen-Gagnon K; Das PK; Saul S; Poirier EZ; Blanc H; Vidalain PO; Merits A; Vignuzzi M
J Virol; 2015 Nov; 89(22):11233-44. PubMed ID: 26311883
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of TLR mediated innate immune response of mouse neuronal cells following infection with novel ECSA genotype of Chikungunya virus with and without E1:A226V mutation.
Priya R; Dhanwani R; Patro IK; Rao PV; Parida MM
Infect Genet Evol; 2013 Dec; 20():396-406. PubMed ID: 24126361
[TBL] [Abstract][Full Text] [Related]
13. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
Akhrymuk I; Lukash T; Frolov I; Frolova EI
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dengue virus resistance to brequinar in cell culture.
Qing M; Zou G; Wang QY; Xu HY; Dong H; Yuan Z; Shi PY
Antimicrob Agents Chemother; 2010 Sep; 54(9):3686-95. PubMed ID: 20606073
[TBL] [Abstract][Full Text] [Related]
15. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
[TBL] [Abstract][Full Text] [Related]
16. Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response.
Cheung NN; Lai KK; Dai J; Kok KH; Chen H; Chan KH; Yuen KY; Kao RYT
J Gen Virol; 2017 May; 98(5):946-954. PubMed ID: 28555543
[TBL] [Abstract][Full Text] [Related]
17. Approaches to the treatment of disease induced by chikungunya virus.
Bettadapura J; Herrero LJ; Taylor A; Mahalingam S
Indian J Med Res; 2013 Nov; 138(5):762-5. PubMed ID: 24434329
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase and stearoyl-CoA desaturase-1 are conserved druggable cofactors of Old World Alphavirus genome replication.
Bakhache W; Neyret A; McKellar J; Clop C; Bernard E; Weger-Lucarelli J; Briant L
Antiviral Res; 2019 Dec; 172():104642. PubMed ID: 31678479
[TBL] [Abstract][Full Text] [Related]
19. Loss of the Nuclear Protein RTF2 Enhances Influenza Virus Replication.
Chia BS; Li B; Cui A; Eisenhaure T; Raychowdhury R; Lieb D; Hacohen N
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878895
[TBL] [Abstract][Full Text] [Related]
20. In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant.
Delogu I; Pastorino B; Baronti C; Nougairède A; Bonnet E; de Lamballerie X
Antiviral Res; 2011 Jun; 90(3):99-107. PubMed ID: 21440006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
